55.69
+1.215(+2.23%)
Currency In USD
| Previous Close | 54.47 |
| Open | 54.76 |
| Day High | 57.48 |
| Day Low | 54.56 |
| 52-Week High | 57.48 |
| 52-Week Low | 7.58 |
| Volume | 809,218 |
| Average Volume | 1.21M |
| Market Cap | 2.36B |
| PE | -16.05 |
| EPS | -3.47 |
| Moving Average 50 Days | 33.51 |
| Moving Average 200 Days | 16.94 |
| Change | 1.22 |
If you invested $1000 in Celcuity Inc. (CELC) since IPO date, it would be worth $3,896.78 as of September 08, 2025 at a share price of $55.685. Whereas If you bought $1000 worth of Celcuity Inc. (CELC) shares 5 years ago, it would be worth $10,647.23 as of September 08, 2025 at a share price of $55.685.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
GlobeNewswire Inc.
Aug 27, 2025 8:05 PM GMT
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to acc
Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call
GlobeNewswire Inc.
Aug 07, 2025 11:05 AM GMT
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the second q
Celcuity Inc. Announces Pricing of Concurrent Public Offerings of 2.750% Convertible Senior Notes Due 2031 and Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Jul 30, 2025 10:30 AM GMT
MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the pricing of its underwritten public offe